JP2015511958A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015511958A5 JP2015511958A5 JP2014560985A JP2014560985A JP2015511958A5 JP 2015511958 A5 JP2015511958 A5 JP 2015511958A5 JP 2014560985 A JP2014560985 A JP 2014560985A JP 2014560985 A JP2014560985 A JP 2014560985A JP 2015511958 A5 JP2015511958 A5 JP 2015511958A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- pharmaceutically acceptable
- compound
- acceptable salt
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 13
- 239000011780 sodium chloride Substances 0.000 claims 13
- 201000010099 disease Diseases 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 9
- 206010012289 Dementia Diseases 0.000 claims 6
- 206010001897 Alzheimer's disease Diseases 0.000 claims 4
- 206010064930 Age-related macular degeneration Diseases 0.000 claims 2
- 102100015650 BACE1 Human genes 0.000 claims 2
- 101700051112 BACE1 Proteins 0.000 claims 2
- 206010057668 Cognitive disease Diseases 0.000 claims 2
- 201000010374 Down syndrome Diseases 0.000 claims 2
- 208000010412 Glaucoma Diseases 0.000 claims 2
- 208000002780 Macular Degeneration Diseases 0.000 claims 2
- 206010044688 Trisomy 21 Diseases 0.000 claims 2
- 230000001404 mediated Effects 0.000 claims 2
- 102000013455 Amyloid beta-Peptides Human genes 0.000 claims 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 claims 1
- 210000004204 Blood Vessels Anatomy 0.000 claims 1
- 208000005145 Cerebral Amyloid Angiopathy Diseases 0.000 claims 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 claims 1
- 206010016202 Familial amyloidosis Diseases 0.000 claims 1
- 210000004558 Lewy Bodies Anatomy 0.000 claims 1
- 206010053643 Neurodegenerative disease Diseases 0.000 claims 1
- 210000002682 Neurofibrillary Tangles Anatomy 0.000 claims 1
- 206010039966 Senile dementia Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000000240 adjuvant Effects 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 230000001054 cortical Effects 0.000 claims 1
- 230000003412 degenerative Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 201000002212 progressive supranuclear palsy Diseases 0.000 claims 1
- MKRCNOJVWDDSML-UHFFFAOYSA-N CC(CC(C1)(CC2C)C(C(N(CCC3COC3)C(N)=N)=O)c3c1ccc(C#N)c3)C2OC Chemical compound CC(CC(C1)(CC2C)C(C(N(CCC3COC3)C(N)=N)=O)c3c1ccc(C#N)c3)C2OC MKRCNOJVWDDSML-UHFFFAOYSA-N 0.000 description 1
Claims (13)
- 医薬としての使用のための、請求項1記載の化合物又はその薬学的に許容し得る塩。
- 薬学的に許容し得る佐剤、希釈剤及び/もしくは担体と混合した請求項1記載の少なくとも1つの化合物又はその薬学的に許容し得る塩を含む、医薬組成物。
- BACE1介在の障害又は疾患の処置における使用のための、請求項1記載の化合物又はその薬学的に許容し得る塩。
- BACE1介在の障害又は疾患が、神経変性障害、認知機能低下、認知機能障害、認知症、及びβ−アミロイド沈着又は神経原線維変化の産生により特徴付けられる疾患からなる群より選択される、請求項4記載の使用のための化合物又はその薬学的に許容し得る塩。
- 障害又は疾患が、アルツハイマー病、トリソミー21(ダウン症)、オランダ型遺伝性アミロイドーシス脳出血(HCHWA−D)、老年認知症、脳アミロイド血管症、変性認知症、血管及び変性由来の混合型認知症、パーキンソン病に関連する認知症、進行性核上性麻痺に関連する認知症、皮質基底変性に関連する認知症、アルツハイマー病のびまん性レビー小体型、萎縮型加齢黄斑変性症(AMD)及び緑内障からなる群より選択される、請求項5記載の使用のための化合物又はその薬学的に許容し得る塩。
- 障害又は疾患が、アルツハイマー病である、請求項6記載の使用のための化合物又はその薬学的に許容し得る塩。
- 障害又は疾患が、緑内障である、請求項6記載の使用のための化合物又はその薬学的に許容し得る塩。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261606786P | 2012-03-05 | 2012-03-05 | |
US61/606,786 | 2012-03-05 | ||
PCT/US2013/028796 WO2013134085A1 (en) | 2012-03-05 | 2013-03-04 | Inhibitors of beta-secretase |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2015511958A JP2015511958A (ja) | 2015-04-23 |
JP2015511958A5 true JP2015511958A5 (ja) | 2016-04-21 |
JP6161643B2 JP6161643B2 (ja) | 2017-07-12 |
Family
ID=47902355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014560985A Expired - Fee Related JP6161643B2 (ja) | 2012-03-05 | 2013-03-04 | β−セクレターゼ阻害剤 |
Country Status (40)
Country | Link |
---|---|
US (4) | US8981112B2 (ja) |
EP (1) | EP2822930B1 (ja) |
JP (1) | JP6161643B2 (ja) |
KR (1) | KR20140138774A (ja) |
CN (1) | CN104271558B (ja) |
AP (1) | AP4029A (ja) |
AR (1) | AR090241A1 (ja) |
AU (2) | AU2013230523B2 (ja) |
BR (1) | BR112014021269A2 (ja) |
CA (1) | CA2864143C (ja) |
CL (1) | CL2014002334A1 (ja) |
CO (1) | CO7091177A2 (ja) |
CY (1) | CY1117543T1 (ja) |
DK (1) | DK2822930T3 (ja) |
EA (1) | EA024995B1 (ja) |
EC (1) | ECSP14020640A (ja) |
ES (1) | ES2568928T3 (ja) |
HK (1) | HK1205739A1 (ja) |
HR (1) | HRP20160415T1 (ja) |
HU (1) | HUE027289T2 (ja) |
IL (1) | IL233887A (ja) |
IN (1) | IN2014DN06710A (ja) |
MA (1) | MA35945B1 (ja) |
ME (1) | ME02390B (ja) |
MX (1) | MX353432B (ja) |
MY (1) | MY171091A (ja) |
NZ (1) | NZ629239A (ja) |
PE (1) | PE20141972A1 (ja) |
PH (1) | PH12014501963A1 (ja) |
PL (1) | PL2822930T3 (ja) |
RS (1) | RS54730B1 (ja) |
SG (1) | SG11201404600VA (ja) |
SI (1) | SI2822930T1 (ja) |
SM (1) | SMT201600114B (ja) |
TN (1) | TN2014000326A1 (ja) |
TW (1) | TWI557112B (ja) |
UA (1) | UA113641C2 (ja) |
UY (1) | UY34654A (ja) |
WO (1) | WO2013134085A1 (ja) |
ZA (1) | ZA201405846B (ja) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2553225C2 (ru) | 2008-05-23 | 2015-06-10 | Сива Корпорейшн | Способ облегчения регенерации |
KR20120001756A (ko) | 2009-03-13 | 2012-01-04 | 비타이 파마슈티컬즈, 인코포레이티드 | 베타세크리타아제 저해제 |
US8889703B2 (en) | 2010-02-24 | 2014-11-18 | Vitae Pharmaceuticals, Inc. | Inhibitors of beta-secretase |
TWI557112B (zh) | 2012-03-05 | 2016-11-11 | 百靈佳殷格翰國際股份有限公司 | β-分泌酶抑制劑 |
WO2013169531A1 (en) | 2012-05-09 | 2013-11-14 | Boehringer Ingelheim International Gmbh | Methods for making oxetan-3-ylmethanamines |
TW201422592A (zh) | 2012-08-27 | 2014-06-16 | Boehringer Ingelheim Int | β-分泌酶抑制劑 |
WO2014052398A1 (en) | 2012-09-28 | 2014-04-03 | Vitae Pharmaceuticals, Inc. | Inhibitor of beta-secretase |
EP2922835B1 (en) | 2012-11-21 | 2017-08-09 | Boehringer Ingelheim International GmbH | Process for making n-sulfinyl alpha-amino amides |
AR102202A1 (es) | 2014-10-07 | 2017-02-08 | Astrazeneca Ab | Compuestos de oxazol y su uso como inhibidores de bace de oxazol |
US9993535B2 (en) | 2014-12-18 | 2018-06-12 | Siwa Corporation | Method and composition for treating sarcopenia |
US10358502B2 (en) | 2014-12-18 | 2019-07-23 | Siwa Corporation | Product and method for treating sarcopenia |
CN109071675A (zh) | 2016-02-19 | 2018-12-21 | Siwa有限公司 | 使用高级糖化终产物(age)的抗体治疗癌症、杀死转移性癌细胞和预防癌症转移的方法和组合物 |
EP3443007A1 (en) | 2016-04-15 | 2019-02-20 | Siwa Corporation | Anti-age antibodies for treating neurodegenerative disorders |
JP2019518763A (ja) | 2016-06-23 | 2019-07-04 | シワ コーポレーション | 様々な疾患及び障害の治療において使用するためのワクチン |
CN109906222B (zh) * | 2016-09-07 | 2023-08-01 | 加利福尼亚大学董事会 | 减少p-tau并且改善认知的变构促肾上腺皮质激素释放因子受体1(crfr1)拮抗剂 |
JP2020516648A (ja) | 2017-04-13 | 2020-06-11 | シワ コーポレーション | ヒト化モノクローナル終末糖化産物抗体 |
US11518801B1 (en) | 2017-12-22 | 2022-12-06 | Siwa Corporation | Methods and compositions for treating diabetes and diabetic complications |
CN113082209A (zh) * | 2021-03-31 | 2021-07-09 | 中国科学技术大学 | Cd4+t细胞源性bace1、ep2、ep4作为阿尔茨海默病治疗靶点的应用 |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5745185A (en) | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
EP0602060A1 (en) | 1991-08-28 | 1994-06-22 | PHARMACIA & UPJOHN COMPANY | Spirocyclic benzopyran imidazolines, their preparation and their use as potassium channel activators |
AU691296B2 (en) | 1994-05-06 | 1998-05-14 | Pharmacopeia Drug Discovery, Inc. | Combinatorial dihydrobenzopyran library |
EP2153832B1 (en) | 2003-12-15 | 2016-03-09 | Merck Sharp & Dohme Corp. | Heterocyclic aspartyl protease inhibitors |
US7592348B2 (en) | 2003-12-15 | 2009-09-22 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7700603B2 (en) | 2003-12-15 | 2010-04-20 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
CA2578600A1 (en) | 2004-06-16 | 2006-01-26 | Wyeth | Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase |
WO2006009653A1 (en) | 2004-06-16 | 2006-01-26 | Wyeth | Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
WO2006044497A2 (en) | 2004-10-13 | 2006-04-27 | Merck & Co., Inc. | Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer’s disease |
WO2006138217A1 (en) | 2005-06-14 | 2006-12-28 | Schering Corporation | Aspartyl protease inhibitors |
CA2610812A1 (en) | 2005-06-14 | 2006-12-28 | Schering Corporation | Aspartyl protease inhibitors |
WO2007005404A1 (en) | 2005-06-30 | 2007-01-11 | Wyeth | AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION |
TW200738683A (en) | 2005-06-30 | 2007-10-16 | Wyeth Corp | Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation |
CN101233274B (zh) | 2005-07-29 | 2011-03-16 | 皇家飞利浦电子股份有限公司 | 从蒸汽熨斗产生蒸汽喷发的方法 |
TW200730523A (en) | 2005-07-29 | 2007-08-16 | Wyeth Corp | Cycloalkyl amino-hydantoin compounds and use thereof for β-secretase modulation |
KR20080050430A (ko) | 2005-09-26 | 2008-06-05 | 와이어쓰 | 베타-세크레타제 (bace) 억제제로서아미노-5-[4-(디플루오로메톡시)페닐]-5-페닐이미다졸론화합물 |
EP2612854B1 (en) | 2005-10-25 | 2015-04-29 | Shionogi&Co., Ltd. | Aminothiazolidine and aminotetrahydrothiazepine derivatives as BACE 1 inhibitors |
US7872009B2 (en) | 2005-11-21 | 2011-01-18 | Amgen Inc. | Beta-Secretase modulators and methods of use |
DE102005057688A1 (de) | 2005-12-01 | 2007-06-14 | Endress + Hauser Flowtec Ag | Vorrichtung zur Bestimmung und/oder Überwachung des Massedurchflusses eines gasförmigen Mediums |
CN101360737A (zh) | 2005-12-19 | 2009-02-04 | 惠氏公司 | 2-氨基-5-哌啶咪唑酮化合物和其用于β分泌酶调节的用途 |
EP1974278A4 (en) | 2005-12-20 | 2012-01-04 | Fieldbus Foundation | SYSTEM AND METHOD FOR IMPLEMENTING INSTRUMENTED SAFETY SYSTEMS |
WO2007100536A1 (en) | 2006-02-24 | 2007-09-07 | Wyeth | DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE |
JP2009539983A (ja) | 2006-06-12 | 2009-11-19 | シェーリング コーポレイション | 複素環式アスパルチルプロテアーゼ阻害薬 |
JP5109974B2 (ja) | 2006-07-18 | 2012-12-26 | アステラス製薬株式会社 | アミノインダン誘導体又はその塩 |
WO2008030412A2 (en) | 2006-09-07 | 2008-03-13 | Merck & Co., Inc. | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
WO2008076043A1 (en) | 2006-12-20 | 2008-06-26 | Astrazeneca Ab | Novel 2-amino-5,5-diaryl-imidazol-4-ones |
TW200831484A (en) | 2006-12-20 | 2008-08-01 | Astrazeneca Ab | New compounds |
TW200831091A (en) | 2006-12-20 | 2008-08-01 | Astrazeneca Ab | New compounds |
CL2008000784A1 (es) | 2007-03-20 | 2008-05-30 | Wyeth Corp | Compuestos amino-5-[-4-(diflourometoxi) fenil sustituido]-5-fenilmidazolona, inhibidores de b-secretasa; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar alzheimer, deterioro cognitivo, sindrome de down, disminucion co |
PE20090617A1 (es) | 2007-03-23 | 2009-05-08 | Wyeth Corp | Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa |
TW200902526A (en) | 2007-04-24 | 2009-01-16 | Shionogi & Amp Co Ltd | Aminodihydrothiazin derivative substituted with a cyclic group |
JP5383483B2 (ja) | 2007-04-24 | 2014-01-08 | 塩野義製薬株式会社 | アルツハイマー症治療用医薬組成物 |
TW200902503A (en) | 2007-05-15 | 2009-01-16 | Astrazeneca Ab | New compounds |
EP2077637B1 (en) | 2007-12-12 | 2020-03-11 | Alcatel Lucent | System and method for protecting payload information in radio transmission |
ES2398017T3 (es) | 2008-02-18 | 2013-03-13 | F. Hoffmann-La Roche Ag | Derivados de 4,5-dihidro-oxazol-2-il-amina |
TWI431004B (zh) | 2008-05-02 | 2014-03-21 | Lilly Co Eli | Bace抑制劑 |
WO2010013302A1 (ja) | 2008-07-28 | 2010-02-04 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スピロアミノジヒドロチアジン誘導体 |
WO2010013794A1 (en) | 2008-07-28 | 2010-02-04 | Eisai R&D Management Co., Ltd. | Spiroaminodihydrothiazine derivatives |
WO2010021680A2 (en) | 2008-08-19 | 2010-02-25 | Vitae Pharmaceuticals, Inc. | Inhibitors of beta-secretase |
AU2009291602B2 (en) | 2008-09-11 | 2013-02-14 | Amgen Inc. | Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use |
PE20110777A1 (es) * | 2008-11-23 | 2011-10-29 | Pfizer | Nuevas lactamas como inhibidores de beta secretasa |
KR20120001756A (ko) * | 2009-03-13 | 2012-01-04 | 비타이 파마슈티컬즈, 인코포레이티드 | 베타세크리타아제 저해제 |
WO2011072064A1 (en) | 2009-12-08 | 2011-06-16 | Array Biopharma Inc. | S piro [chroman - 4, 4 ' - imidazol] ones as beta - secretase inhibitors |
US8889703B2 (en) | 2010-02-24 | 2014-11-18 | Vitae Pharmaceuticals, Inc. | Inhibitors of beta-secretase |
US20120065195A1 (en) | 2010-03-31 | 2012-03-15 | Clark Christopher T | Compounds for treating neurodegenerative diseases |
US8415483B2 (en) * | 2010-12-22 | 2013-04-09 | Astrazeneca Ab | Compounds and their use as BACE inhibitors |
TWI557112B (zh) | 2012-03-05 | 2016-11-11 | 百靈佳殷格翰國際股份有限公司 | β-分泌酶抑制劑 |
-
2013
- 2013-02-06 TW TW102104519A patent/TWI557112B/zh not_active IP Right Cessation
- 2013-03-04 EP EP13710937.7A patent/EP2822930B1/en active Active
- 2013-03-04 IN IN6710DEN2014 patent/IN2014DN06710A/en unknown
- 2013-03-04 US US13/784,032 patent/US8981112B2/en active Active
- 2013-03-04 DK DK13710937.7T patent/DK2822930T3/en active
- 2013-03-04 WO PCT/US2013/028796 patent/WO2013134085A1/en active Application Filing
- 2013-03-04 KR KR1020147026838A patent/KR20140138774A/ko not_active Application Discontinuation
- 2013-03-04 CN CN201380012529.9A patent/CN104271558B/zh not_active Expired - Fee Related
- 2013-03-04 PL PL13710937.7T patent/PL2822930T3/pl unknown
- 2013-03-04 AP AP2014007900A patent/AP4029A/en active
- 2013-03-04 ES ES13710937.7T patent/ES2568928T3/es active Active
- 2013-03-04 JP JP2014560985A patent/JP6161643B2/ja not_active Expired - Fee Related
- 2013-03-04 RS RS20160246A patent/RS54730B1/sr unknown
- 2013-03-04 SG SG11201404600VA patent/SG11201404600VA/en unknown
- 2013-03-04 PE PE2014001347A patent/PE20141972A1/es active IP Right Grant
- 2013-03-04 NZ NZ629239A patent/NZ629239A/en not_active IP Right Cessation
- 2013-03-04 UA UAA201410695A patent/UA113641C2/uk unknown
- 2013-03-04 BR BR112014021269A patent/BR112014021269A2/pt active Search and Examination
- 2013-03-04 SI SI201330173A patent/SI2822930T1/sl unknown
- 2013-03-04 UY UY0001034654A patent/UY34654A/es active IP Right Grant
- 2013-03-04 EA EA201491534A patent/EA024995B1/ru not_active IP Right Cessation
- 2013-03-04 CA CA2864143A patent/CA2864143C/en not_active Expired - Fee Related
- 2013-03-04 MX MX2014010625A patent/MX353432B/es active IP Right Grant
- 2013-03-04 ME MEP-2016-74A patent/ME02390B/me unknown
- 2013-03-04 AU AU2013230523A patent/AU2013230523B2/en not_active Ceased
- 2013-03-04 MY MYPI2014002293A patent/MY171091A/en unknown
- 2013-03-04 HU HUE13710937A patent/HUE027289T2/en unknown
- 2013-03-05 AR ARP130100706A patent/AR090241A1/es active IP Right Grant
-
2014
- 2014-07-30 IL IL233887A patent/IL233887A/en active IP Right Grant
- 2014-07-31 TN TNP2014000326A patent/TN2014000326A1/fr unknown
- 2014-08-08 ZA ZA2014/05846A patent/ZA201405846B/en unknown
- 2014-09-02 PH PH12014501963A patent/PH12014501963A1/en unknown
- 2014-09-02 CL CL2014002334A patent/CL2014002334A1/es unknown
- 2014-09-26 MA MA37375A patent/MA35945B1/fr unknown
- 2014-09-29 EC ECIEPI201420640A patent/ECSP14020640A/es unknown
- 2014-09-29 CO CO14215177A patent/CO7091177A2/es unknown
-
2015
- 2015-02-04 US US14/613,550 patent/US9526727B2/en active Active
- 2015-06-30 HK HK15106248.0A patent/HK1205739A1/zh not_active IP Right Cessation
-
2016
- 2016-04-19 SM SM201600114T patent/SMT201600114B/it unknown
- 2016-04-19 CY CY20161100327T patent/CY1117543T1/el unknown
- 2016-04-20 HR HRP20160415TT patent/HRP20160415T1/hr unknown
- 2016-12-19 US US15/383,287 patent/US9949975B2/en active Active
-
2017
- 2017-10-02 AU AU2017236042A patent/AU2017236042B2/en not_active Ceased
-
2018
- 2018-03-12 US US15/918,546 patent/US20180344734A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2015511958A5 (ja) | ||
HRP20160415T1 (hr) | Inhibitori beta-sekretaze | |
JP2015512951A5 (ja) | ||
MX2017013483A (es) | Compuestos y su uso como inhibidores de ?-secretasa 1 (bace1). | |
JP2013525444A5 (ja) | ||
RU2014145682A (ru) | Органические соединения | |
EP4275748A3 (en) | Compositions and methods for treating cns disorders | |
JP2016513130A5 (ja) | ||
HRP20160185T1 (hr) | Spojevi iminotiadiazin dioksida kao inhibitori bace, smjese i njihova uporaba | |
JP2015501783A5 (ja) | ||
EP4252848A3 (en) | Oxysterols and methods of use thereof | |
CL2018000036A1 (es) | Derivados etinilo | |
JP2014507455A5 (ja) | ||
JP2016535786A5 (ja) | ||
JP2015537020A5 (ja) | ||
JP2014506907A5 (ja) | ||
JP2015500223A5 (ja) | ||
JP2012521994A5 (ja) | ||
JP2020502092A5 (ja) | ||
JP2013032389A5 (ja) | ||
JP2016503010A5 (ja) | ||
JP2014500861A5 (ja) | ||
JP2015500257A5 (ja) | ||
JP2016510326A5 (ja) | ||
JP2008535860A5 (ja) |